600 patients66,869 observations120 daysLIVE

Patient P-01739

Synthetic patientNBL-101 · Day 116 · 65–74 · M · baseline S14Steering view · 3DOpen companion preview
Therapy response
Stable
Tolerance
Improving
GI state
Unstable
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
96%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 45 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 72 ME-01 recommendedMonitoring Escalation ME-01
  4. Day 73 Patient acceptedStarted ME-01 in the companion
  5. Day 76 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory began diverging from predicted response on Day 45.

Primary contributors, last 14 days
  • Inflammatory activity+8
  • GI instability+7
  • Nutritional resilience-5
  • Toxicity-5
  • Treatment adherence-4

What helped?

  • Monitoring Escalation ME-01Day 72
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
GI Support Protocol GI-04
92%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 83% showed improvement
  • median effect visible after 8 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
68.3/100
worsening · +10.2 vs previous 14 d
Toxicity
Blood
46/100
stable · +0.1 vs previous 14 d
Sleep quality
Wearable
16.6/100
worsening · -5.8 vs previous 14 d
Energy level
Daily log
2.2/10
worsening · -0.5 vs previous 14 d
Stress level
Daily log
6.9/10
worsening · +0.4 vs previous 14 d
Steps
Wearable
7,410
worsening · -351 vs previous 14 d
Adherence
Companion
41.5 %
stable · +1.5 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 20 from the failing basin, 76 from restoration.

Would help
  • GI-04 GI Support Protocol
    73% improved among 124 similar · onset 8 d · confidence 97%
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 80%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 80%
Would not help
  • Keep simple carbs low
    GI +3.2 next day on high-intake days · n 15
  • Keep alcohol low
    GI +3.1 next day on high-intake days · n 20
  • Keep fibre low
    GI +2.7 next day on high-intake days · n 17
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Simple carbohydrates
    +3.2detractor · 95%
  • Alcohol
    +3.1detractor · 95%
  • Insoluble fibre
    +2.7detractor · 94%
  • Dietary fat load
    +0.9no signal · 25%
  • Histamine load
    -0.5no signal · 15%
  • Spicy / capsaicin
    -0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 60
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 68 and rising
    • WearableSleep 5.6 h, below personal baseline
  • Inflammatory signalling 60
    • MicrobiomeBacteroides fragilis expansion
    • BloodInflammatory load index 68
    • WearableHRV 21 ms, trending down
  • Drug metabolism and exposure 55
    • DNADPYD *2A → slower clearance
    • BloodToxicity index 46
  • Butyrate / short-chain fatty acid production 45
    • MicrobiomeF. prausnitzii depleted
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 45
    • WearableResting HR 84 bpm
    • WearableShort sleep window
DNA
Fictional pharmacogenomic panel
  • DPYD *2A heterozygous
    Slower drug clearance
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2.6 · butyrate capacity 48/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
21 ms
Sleep
5.6 h
Steps
6,870
Resting HR
85 bpm
Daily log: GI score 68, nutritional resilience 30, adherence 42.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Protect a 7.5-hour sleep window; screens off 30 minutes before
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0181348%S01NP-02no change40
P-0132735%S01GI-04improved56
P-0168830%S01GI-04improved40
P-0131029%S0157
P-0187726%S01CR-01improved67
P-0182119%S0158
P-0182319%S0157
P-0160418%S0171
P-0169518%S0130
P-0163532%S02GI-04improved49
P-0145229%S02GI-04improved46
P-0145928%S0251